No black box warning on record for Clariscan

As of the latest FDA labeling reviewed, Clariscan (GADOTERATE MEGLUMINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Clariscan medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Anaphylactoid/anaphylactic reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have uncommonly occurred. Monitor patients closely for need of emergency cardiorespiratory support. ( 5.3 ) Gadolinium Retention: Gadolinium is retained for months or years in brain, bone, and other o

No black box warning on record for Clariscan

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Anaphylactoid/anaphylactic reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have uncommonly occurred. Monitor patients closely for need of emergency cardiorespiratory support. ( 5.3 ) Gadolinium Retention: Gadolinium is retained for months or years in brain, bone, and other o

Clariscan Black Box Warning

No black box warning on record for Clariscan

Other warnings & precautions

Clariscan Black Box Warning

No black box warning on record for Clariscan

Other warnings & precautions